News

Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies ...
Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to ...
TMC the metals company Inc. (Nasdaq: TMC) (“TMC” or the “Company”), an explorer of the world’s largest undeveloped resource of critical metals for building infrastructure, defense technologies, energy ...
Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced preclinical data from four pipeline ...
Altamira Therapeutics Ltd. ("Altamira" or the "Company") (OTCQB: CYTOF), a company dedicated to developing and commercializing RNA delivery technology for targets beyond the liver, today announced ...
TopBuild Corp. (NYSE:BLD), a leading installer and specialty distributor of insulation and building material products to the construction industry in the United States and Canada, today announced that ...
Currently, the focus is on increasing occupancy rates and debt repayment. Although we had previously accounted for the one-off loss of EUR 67.4m They now equal EUR 21.9m (prev. EUR 24.4m) for revenues ...
BlackRock Asset Management Canada Limited (“BlackRock Canada”), an indirect, wholly-owned subsidiary of BlackRock, Inc. (NYSE: BLK), today announced the final April 2025 cash distributions for the ...
Die Aktie von Hilton Worldwide zeigt sich vor der anstehenden Quartalsbericht-Veröffentlichung am kommenden Dienstag in einer volatilen Phase. Nach einem schwachen April mit einem Minus von über 8% ...
Die Teleperformance-Aktie zeigt heute eine leichte Abschwächung nach ihrer jüngsten Aufwärtsbewegung. Mit einem Minus von 0,54% notiert das Papier bei 51,82 USD und gibt damit einen Teil der jüngsten ...
Die Jupiter Management Aktie zeigt weiterhin Schwäche: Mit einem Minus von fast 3% im Monat und über 6% im Jahr bleibt der Titel deutlich unter seinem 52-Wochen-Hoch. Die jüngsten Nettoabflüsse und ...